Skip to content
10-K

Annual Report

BIOREGENX, INC. BRGX

0001683168-26-002975

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2026 969.02M sh
Shares Diluted FY 2025 · Dec 31, 2025 959.71M sh
Capex FY 2025 · Dec 31, 2025 $9.06K
Operating Cash Flow FY 2025 · Dec 31, 2025 $38.97K
Long Term Debt FY 2025 · Dec 31, 2025 $181.83K
Short Term Debt FY 2025 · Dec 31, 2025 $1M
Stockholders Equity FY 2025 · Dec 31, 2025 −$4.54M
Current Liabilities FY 2025 · Dec 31, 2025 $4.07M
Total Liabilities FY 2025 · Dec 31, 2025 $4.95M
Current Assets FY 2025 · Dec 31, 2025 $251.27K
Total Assets FY 2025 · Dec 31, 2025 $410.99K
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $2.01M
Rd Expense FY 2025 · Dec 31, 2025 $31.75K
Net Income FY 2025 · Dec 31, 2025 −$1.54M
Operating Income FY 2025 · Dec 31, 2025 −$1.24M
Gross Profit FY 2025 · Dec 31, 2025 $1.5M
Cost Of Revenue FY 2025 · Dec 31, 2025 $350.86K
Revenue FY 2025 · Dec 31, 2025 $1.85M